Annual FCF
-$7.00 M
+$449.90 K+6.04%
30 June 2024
Summary:
InMed Pharmaceuticals annual free cash flow is currently -$7.00 million, with the most recent change of +$449.90 thousand (+6.04%) on 30 June 2024. During the last 3 years, it has risen by +$2.80 million (+28.57%). INM annual FCF is now -7060.30% below its all-time high of $100.50 thousand, reached on 30 June 2009.INM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$1.83 M
-$797.60 K-77.50%
30 September 2024
Summary:
InMed Pharmaceuticals quarterly free cash flow is currently -$1.83 million, with the most recent change of -$797.60 thousand (-77.50%) on 30 September 2024. Over the past year, it has increased by +$347.40 thousand (+15.98%). INM quarterly FCF is now -202.11% below its all-time high of $1.79 million, reached on 30 June 2005.INM Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$6.65 M
+$347.40 K+4.97%
30 September 2024
Summary:
InMed Pharmaceuticals TTM free cash flow is currently -$6.65 million, with the most recent change of +$347.40 thousand (+4.97%) on 30 September 2024. Over the past year, it has increased by +$715.90 thousand (+9.72%). INM TTM FCF is now -710.16% below its all-time high of $1.09 million, reached on 31 December 2005.INM TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INM Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6.0% | +16.0% | +9.7% |
| 3 y3 years | +28.6% | +31.2% | +40.0% |
| 5 y5 years | -4.3% | +23.8% | +14.4% |
INM Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +55.2% | -164.2% | +65.9% | -2.1% | +57.5% |
| 5 y | 5 years | -4.3% | +55.2% | -164.2% | +65.9% | -9.0% | +57.5% |
| alltime | all time | -7060.3% | +55.2% | -202.1% | +65.9% | -710.2% | +57.5% |
InMed Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.83 M(+77.5%) | -$6.65 M(-5.0%) |
| June 2024 | -$7.00 M(-6.0%) | -$1.03 M(-46.8%) | -$7.00 M(+5.1%) |
| Mar 2024 | - | -$1.93 M(+4.1%) | -$6.66 M(+2.3%) |
| Dec 2023 | - | -$1.86 M(-14.6%) | -$6.51 M(-11.6%) |
| Sept 2023 | - | -$2.17 M(+214.4%) | -$7.36 M(-1.1%) |
| June 2023 | -$7.45 M(-52.3%) | -$691.50 K(-61.3%) | -$7.44 M(-31.1%) |
| Mar 2023 | - | -$1.78 M(-34.2%) | -$10.80 M(-24.8%) |
| Dec 2022 | - | -$2.71 M(+20.3%) | -$14.37 M(-5.6%) |
| Sept 2022 | - | -$2.26 M(-44.3%) | -$15.22 M(-2.6%) |
| June 2022 | -$15.62 M(+59.5%) | -$4.05 M(-24.4%) | -$15.62 M(+15.0%) |
| Mar 2022 | - | -$5.35 M(+49.9%) | -$13.58 M(+5.8%) |
| Dec 2021 | - | -$3.57 M(+34.5%) | -$12.84 M(+16.0%) |
| Sept 2021 | - | -$2.65 M(+32.3%) | -$11.07 M(+13.1%) |
| June 2021 | -$9.79 M(+32.0%) | -$2.01 M(-56.5%) | -$9.79 M(+6.6%) |
| Mar 2021 | - | -$4.61 M(+156.0%) | -$9.18 M(+50.5%) |
| Dec 2020 | - | -$1.80 M(+31.3%) | -$6.10 M(-4.5%) |
| Sept 2020 | - | -$1.37 M(-1.9%) | -$6.39 M(-13.8%) |
| June 2020 | -$7.42 M(+10.6%) | -$1.40 M(-8.6%) | -$7.42 M(-6.7%) |
| Mar 2020 | - | -$1.53 M(-26.9%) | -$7.95 M(-7.2%) |
| Dec 2019 | - | -$2.09 M(-12.7%) | -$8.56 M(+10.2%) |
| Sept 2019 | - | -$2.40 M(+24.3%) | -$7.77 M(+15.8%) |
| June 2019 | -$6.71 M(+86.6%) | -$1.93 M(-10.0%) | -$6.71 M(+16.2%) |
| Mar 2019 | - | -$2.14 M(+64.8%) | -$5.77 M(+33.7%) |
| Dec 2018 | - | -$1.30 M(-2.6%) | -$4.32 M(+12.5%) |
| Sept 2018 | - | -$1.33 M(+34.5%) | -$3.84 M(+6.8%) |
| June 2018 | -$3.59 M(+50.7%) | -$992.70 K(+44.2%) | -$3.59 M(+4.7%) |
| Mar 2018 | - | -$688.40 K(-16.3%) | -$3.43 M(-1.7%) |
| Dec 2017 | - | -$822.10 K(-24.7%) | -$3.49 M(+5.5%) |
| Sept 2017 | - | -$1.09 M(+31.1%) | -$3.31 M(+38.8%) |
| June 2017 | -$2.38 M(+516.3%) | -$832.60 K(+11.3%) | -$2.38 M(+47.2%) |
| Mar 2017 | - | -$748.20 K(+17.1%) | -$1.62 M(+68.9%) |
| Dec 2016 | - | -$639.20 K(+287.4%) | -$959.40 K(+126.4%) |
| Sept 2016 | - | -$165.00 K(+141.9%) | -$423.70 K(+9.5%) |
| June 2016 | -$387.00 K(-76.0%) | -$68.20 K(-21.6%) | -$386.90 K(-64.1%) |
| Mar 2016 | - | -$87.00 K(-15.9%) | -$1.08 M(-34.6%) |
| Dec 2015 | - | -$103.50 K(-19.3%) | -$1.65 M(+0.7%) |
| Sept 2015 | - | -$128.20 K(-83.1%) | -$1.64 M(+1.6%) |
| June 2015 | -$1.61 M(+150.6%) | -$759.70 K(+15.4%) | -$1.61 M(+8.1%) |
| Mar 2015 | - | -$658.20 K(+617.0%) | -$1.49 M(+79.1%) |
| Dec 2014 | - | -$91.80 K(-10.5%) | -$832.60 K(+12.3%) |
| Sept 2014 | - | -$102.60 K(-83.9%) | -$741.20 K(+15.6%) |
| June 2014 | -$643.40 K(+1537.2%) | -$638.80 K(<-9900.0%) | -$641.40 K(<-9900.0%) |
| Mar 2014 | - | $600.00(-250.0%) | $800.00(-27.3%) |
| Dec 2013 | - | -$400.00(-85.7%) | $1100.00(-107.7%) |
| Sept 2013 | - | -$2800.00(-182.4%) | -$14.20 K(-63.9%) |
| June 2013 | -$39.30 K | $3400.00(+277.8%) | -$39.30 K(-52.5%) |
| Mar 2013 | - | $900.00(-105.7%) | -$82.80 K(-18.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2012 | - | -$15.70 K(-43.7%) | -$102.00 K(-37.2%) |
| Sept 2012 | - | -$27.90 K(-30.4%) | -$162.40 K(-7.0%) |
| June 2012 | -$174.60 K(-68.9%) | -$40.10 K(+119.1%) | -$174.60 K(-65.2%) |
| Mar 2012 | - | -$18.30 K(-76.0%) | -$501.40 K(-24.5%) |
| Dec 2011 | - | -$76.10 K(+89.8%) | -$664.00 K(+11.0%) |
| Sept 2011 | - | -$40.10 K(-89.1%) | -$598.30 K(+6.4%) |
| June 2011 | -$562.10 K(+187.7%) | -$366.90 K(+102.8%) | -$562.10 K(+129.3%) |
| Mar 2011 | - | -$180.90 K(+1639.4%) | -$245.10 K(+115.4%) |
| Dec 2010 | - | -$10.40 K(+166.7%) | -$113.80 K(-21.2%) |
| Sept 2010 | - | -$3900.00(-92.2%) | -$144.50 K(-26.0%) |
| June 2010 | -$195.40 K(-294.4%) | -$49.90 K(+0.6%) | -$195.40 K(-492.4%) |
| Mar 2010 | - | -$49.60 K(+20.7%) | $49.80 K(-34.6%) |
| Dec 2009 | - | -$41.10 K(-25.0%) | $76.20 K(-48.1%) |
| Sept 2009 | - | -$54.80 K(-128.1%) | $146.80 K(+46.2%) |
| June 2009 | $100.50 K(-110.3%) | $195.30 K(-941.8%) | $100.40 K(-119.9%) |
| Mar 2009 | - | -$23.20 K(-178.6%) | -$503.50 K(-579.1%) |
| Dec 2008 | - | $29.50 K(-129.2%) | $105.10 K(-113.0%) |
| Sept 2008 | - | -$101.20 K(-75.2%) | -$810.50 K(-17.0%) |
| June 2008 | -$976.00 K(-30.7%) | -$408.60 K(-169.8%) | -$976.00 K(-20.5%) |
| Mar 2008 | - | $585.40 K(-166.1%) | -$1.23 M(-38.2%) |
| Dec 2007 | - | -$886.10 K(+232.2%) | -$1.99 M(+72.0%) |
| Sept 2007 | - | -$266.70 K(-59.6%) | -$1.16 M(-17.9%) |
| June 2007 | -$1.41 M(+143.8%) | -$660.40 K(+279.5%) | -$1.41 M(+129.4%) |
| Mar 2007 | - | -$174.00 K(+221.6%) | -$613.70 K(-5.6%) |
| Dec 2006 | - | -$54.10 K(-89.6%) | -$649.80 K(-24.4%) |
| Sept 2006 | - | -$519.20 K(-488.6%) | -$859.30 K(+48.8%) |
| June 2006 | -$577.40 K(-18.6%) | $133.60 K(-163.6%) | -$577.30 K(-153.5%) |
| Mar 2006 | - | -$210.10 K(-20.3%) | $1.08 M(-1.0%) |
| Dec 2005 | - | -$263.60 K(+11.1%) | $1.09 M(-240.7%) |
| Sept 2005 | - | -$237.20 K(-113.3%) | -$774.30 K(+9.1%) |
| June 2005 | -$709.50 K(+42.0%) | $1.79 M(-1000.4%) | -$709.50 K(-76.2%) |
| Mar 2005 | - | -$198.70 K(-90.7%) | -$2.98 M(-1.6%) |
| Dec 2004 | - | -$2.13 M(+1134.0%) | -$3.03 M(+309.5%) |
| Sept 2004 | - | -$172.40 K(-64.1%) | -$739.10 K(+47.9%) |
| July 2004 | -$499.60 K(-42.5%) | -$479.70 K(+94.2%) | -$499.60 K(+48.2%) |
| Apr 2004 | - | -$247.00 K(-254.4%) | -$337.10 K(+18.8%) |
| Jan 2004 | - | $160.00 K(+138.5%) | -$283.80 K(-53.8%) |
| Oct 2003 | - | $67.10 K(-121.2%) | -$614.90 K(-29.3%) |
| July 2003 | -$869.20 K(-24.8%) | -$317.20 K(+63.8%) | -$869.30 K(+22.8%) |
| Apr 2003 | - | -$193.70 K(+13.2%) | -$708.00 K(-15.1%) |
| Jan 2003 | - | -$171.10 K(-8.6%) | -$834.10 K(-11.3%) |
| Oct 2002 | - | -$187.30 K(+20.1%) | -$940.60 K(-18.6%) |
| July 2002 | -$1.16 M(-6.4%) | -$155.90 K(-51.3%) | -$1.16 M(+15.6%) |
| Apr 2002 | - | -$319.80 K(+15.2%) | -$1.00 M(+47.0%) |
| Jan 2002 | - | -$277.60 K(-31.1%) | -$680.30 K(+68.9%) |
| Oct 2001 | - | -$402.70 K | -$402.70 K |
| July 2001 | -$1.24 M | - | - |
FAQ
- What is InMed Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for InMed Pharmaceuticals?
- What is InMed Pharmaceuticals annual FCF year-on-year change?
- What is InMed Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for InMed Pharmaceuticals?
- What is InMed Pharmaceuticals quarterly FCF year-on-year change?
- What is InMed Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for InMed Pharmaceuticals?
- What is InMed Pharmaceuticals TTM FCF year-on-year change?
What is InMed Pharmaceuticals annual free cash flow?
The current annual FCF of INM is -$7.00 M
What is the all time high annual FCF for InMed Pharmaceuticals?
InMed Pharmaceuticals all-time high annual free cash flow is $100.50 K
What is InMed Pharmaceuticals annual FCF year-on-year change?
Over the past year, INM annual free cash flow has changed by +$449.90 K (+6.04%)
What is InMed Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of INM is -$1.83 M
What is the all time high quarterly FCF for InMed Pharmaceuticals?
InMed Pharmaceuticals all-time high quarterly free cash flow is $1.79 M
What is InMed Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, INM quarterly free cash flow has changed by +$347.40 K (+15.98%)
What is InMed Pharmaceuticals TTM free cash flow?
The current TTM FCF of INM is -$6.65 M
What is the all time high TTM FCF for InMed Pharmaceuticals?
InMed Pharmaceuticals all-time high TTM free cash flow is $1.09 M
What is InMed Pharmaceuticals TTM FCF year-on-year change?
Over the past year, INM TTM free cash flow has changed by +$715.90 K (+9.72%)